Cargando…
Management of multiple sclerosis patients in central European countries: current needs and potential solutions
Multiple sclerosis (MS) experts in Europe are facing rapidly rising demands of excellence due to the increasing complexity of MS therapy and management. A central European expert board of MS experts met to identify needs and obstacles with respect to raising quality of MS care in central and Eastern...
Autores principales: | Berger, Thomas, Adamczyk-Sowa, Monika, Csépány, Tünde, Fazekas, Franz, Hojs Fabjan, Tanja, Horáková, Dana, Illes, Zsolt, Klimová, Eleonóra, Leutmezer, Fritz, Rejdak, Konrad, Rozsa, Csilla, Šega Jazbec, Saša, Szilasiová, Jarmila, Turčáni, Peter, Vachová, Marta, Vécsei, László, Havrdová, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826096/ https://www.ncbi.nlm.nih.gov/pubmed/29511382 http://dx.doi.org/10.1177/1756286418759189 |
Ejemplares similares
-
Factors influencing daily treatment choices in multiple sclerosis:
practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020) -
How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?
por: Fazekas, Franz, et al.
Publicado: (2013) -
Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
por: Rajda, Cecilia, et al.
Publicado: (2023) -
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
por: Biernacki, Tamás, et al.
Publicado: (2022) -
Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort
por: Hayden, Zsófia, et al.
Publicado: (2021)